Introduction {#sec1}
============

The goal of improving human--animal disease surveillance in West Africa remains an active concept note towards stepwise elimination of rabies in Africa by 2030 \[[@ref1]\]. Although it has been more than seven decades since the first medical report of clinical diagnosis of rabies in dog bite victims (DBVs) in Liberia \[[@ref2]\], the disease remains a neglected public health challenge associated with acute, progressive and highly fatal viral encephalomyelitis of warm-blooded animals (especially dogs) and humans \[[@ref3], [@ref4]\]. The extremely high rabies case fatality rate of nearly 100% makes it the deadliest of all known infections that are transmissible between animals and human beings. Yet, in post-conflict Liberia where dog-transmitted human rabies (DTHR) is enzootic, active surveillance for cases has been relatively neglected \[[@ref3], [@ref4]\], and the country is regarded as one of the remaining dark corners of rabies in Africa \[[@ref5]\]. Periodic evaluation of the rabies status of many developing world countries such as Liberia is hampered by misdiagnosis, under-reporting, poor surveillance and unreliable data gathering at the local level \[[@ref5]\]. However, with the emergence of Rabies in West Africa (RIWA) forum \[[@ref6]\], there has been an increase in scientific studies and reports on rabies at the human--animal interface at various locations in Liberia, including Lofa County in the north, Bong County in the north-central and Grand Bassa County in the west-central region of the country \[[@ref3]\], and also in Montserrado County, home to Monrovia the political capital of the country in the northwest region \[[@ref4]\].

The high incidence of DTHR cases in Liberia has been attributed to poor vaccination coverage of owned dogs, the large population of stray dogs in urban areas, weak enforcement of dog control laws and difficulties in the cold-chain maintenance of vaccines in the post-conflict era \[[@ref4]\]. Other factors include poor health care-seeking behaviour of DBVs, the high cost of rabies post-exposure prophylaxis, and a tendency of some DBVs to seek indigenous rather than orthodox healthcare \[[@ref4]\]. While it is known that rabies is caused by all the 16 virus species currently listed under the order Mononegavirales, family Rhabdoviridae and genus Lyssavirus (bullet-shaped, single-stranded, negative-sense RNA viruses), \[[@ref7]\] little has been done to characterise those that are in circulation in Liberia. Elsewhere, lyssaviruses that have been characterised include Aravan lyssavirus; Khujand lyssavirus; Irkut lyssavirus; Rabies lyssavirus (RABV); Duvenhage lyssavirus; European bat lyssavirus type 1; European bat lyssavirus type 2; Bokeloh bat lyssavirus; Australian bat lyssavirus; Lagos bat lyssavirus (LBV); Mokola lyssavirus (MOKV); Shimoni bat lyssavirus; West Caucasian bat lyssavirus; Ikoma lyssavirus (IKOV); Gannoruwa bat lyssavirus; and Lleida bat lyssavirus \[[@ref7]\]. Of these lyssaviruses, the prototype and most commonly incriminated species in rabies epizootics worldwide is RABV \[[@ref8]\]. An estimated 60 000 human rabies deaths occur each year, mostly among DBVs who are below the age of 15 years and resident in developing countries of Africa and Asia where cases are grossly under-reported \[[@ref9]\].

To our best knowledge, the species, strains and phylogeny of lyssaviruses responsible for human and animal rabies in Liberia have not been previously identified or reported in medical literature. This was evident in the complete absence of accessioned rabies virus genes from Liberia in the NCBI or any other gene bank, before the three deposited from this study. Since a majority of the reported human rabies cases in Liberia are traceable to the bites of suspected rabid dogs \[[@ref2]--[@ref4]\], we hypothesised that dog-adapted RABV variants are responsible for enzootic rabies in the country. In this study, we aimed to characterise the causative strains and phylogeny of rabies viruses at the dog--human interface in Liberia for the first time.

Methods {#sec2}
=======

Ethical approval {#sec2-1}
----------------

The ethical approval (EC/LIBR/014/039) entitled 'Ethical approval for spatio-temporal epidemiology of suspected human cases of rabies, habitat suitability for rabies virus circulation, and molecular investigations, Liberia' was granted by the Liberian Biomedical Research Institute (LIBR).

Study locations {#sec2-2}
---------------

The study was primarily conducted in Monrovia city (also known as Greater Monrovia), in Liberia ([Fig. 1](#fig01){ref-type="fig"}). Monrovia (population: 970 824) is located on latitude 6°18′48″N and longitude 10°48′5″W in Montserrado, the oldest of the 15 Counties of the government of the Republic of Liberia. Monrovia is the administrative and financial capital of Liberia, and also the most densely populated location in the entire country \[[@ref10]\]. The climate of the area is tropical with a distinct wet season that lasts from May to November and a dry season that lasts from December to April, each year. A Central Veterinary Laboratory and Clinic (CVLC) is located in Fendel, a small town, East of Monrovia within Montserrado County. Fig. 1.Map of Liberia in the West coast of Africa (a), Montserrado in the West coast of the country (b), and the four districts of Montserrado including Monrovia, the national capital (c).

The CVLC kept an archive of specimens that comprised brain tissues (mainly brain stem and hippocampus) of suspected rabid dogs (*n* = 110), killed during outbreaks of canine rabies within and around two Monrovia communities -- Paynesville, including the Red Light neighbourhood, and Duala -- from June to October 2016 and from September to October 2017.

Passive surveillance of human--animal rabies in Liberia {#sec2-3}
-------------------------------------------------------

The chronic neglect of rabies research in Liberia \[[@ref11]\] received decisive attention by January 2012, when the University of Ibadan, Nigeria (UI) sponsored a 3-year project to improve postgraduate programmes for surveillance of human--animal diseases in West Africa. The programme enrolled career persons from the Ministries of Health, Agriculture and Universities in Liberia, Nigeria and Sierra Leone, into a one-health strategic surveillance of rabies programme, coordinated by the Centre for Control and Prevention of Zoonoses (CCPZ), University of Ibadan. The purpose was to address the paucity of verifiable rabies statistics in these West African countries, by gathering pertinent spatio-temporal and molecular data on human and animal cases of the disease. In furtherance of these activities, the RIWA forum was inaugurated at the University of Ibadan, Nigeria, December 2012 \[[@ref6]\].

Active surveillance for Lyssavirus species in Liberia {#sec2-4}
-----------------------------------------------------

Active surveillance for Lyssavirus species in Liberia commenced in March 2014. At the time, there were no trained personnel and laboratory facilities for rabies diagnosis in Liberia. There were also no cold storage facilities available for the preservation of rabies suspect tissues. Against this backdrop, we decided to use Whatman^®^ FTA^®^ (Flinders Technology Associates) cards to collect and preserve rabies diagnostic samples including saliva, oro-pharyngeal secretions and brain tissues, for analysis at a later date. FTA cards have a filter paper component that is laced with proprietary chemicals that lyse cells and stabilise nucleic acids on contact, ensuring safe and long-term storage even at room temperature.

Serial saliva samples were obtained from a 10-year-old female DBV who was admitted to the Referral Clinic for Rabies Exposure in Monrovia, 2 months post-exposure with signs of clinical rabies. In April of 2014, the collection of rabies diagnostic samples was suspended in Liberia due to Ebola Virus Disease epidemic in the country. By the time sampling resumed in June 2016, the Liberian Government had set in motion a plan to upgrade the CVLC in Fendel, Monrovia. A solar-powered deep freezer facility and an archive of frozen dog brain tissue samples were soon established.

From the archive, a total of 19 dog brain samples were randomly selected for molecular tests to detect Lyssavirus infections. The samples were preserved in Ethanol 99% concentration, making them harmless and non-infections materials during shipment to laboratories in Nigeria where investigations aimed at detecting and determining the species, strain and phylogeny of the causative *Lyssavirus* were conducted at the Molecular Biology Laboratories of the Center for Control and Prevention of Zoonoses (CCPZ), University of Ibadan, Nigeria, and the National Veterinary Research Institute (NVRI), Vom, Plateau State, Nigeria. Sequencing of amplicons were conducted at the Biosciences Laboratory \[[@ref11]\], International Institute of Tropical Agriculture (IITA), Ibadan, Nigeria. A summary presentation of the test specimens collected at the dog--human interface in Liberia during the course of field survey is presented in [Table 1](#tab01){ref-type="table"}. Table 1.Rabies diagnostic samples collected in Monrovia, Liberia for molecular and phylogenetic analysisSerial No.Lab. IDDate of collectionSpeciesSource locationTypes of sampleBrain tissuesOtherRT-PCR1CCPZUI/HS/3522 March 2014*Homo sapiens*Paynesville, Monrovia, LiberiaNoDrool saliva[^a^](#tfn1_1){ref-type="table-fn"}Negative2DBS/00420 June 2016*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative3DBS/0115 October 2016*Canis familiaris*Duala, Monrovia North, LiberiaYesNoPositive; GenBank Accession No. MF7657584DBS/02004 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative5DBS/03013 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative6DBS/03414 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative7DBS/03915 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative8DBS/04416 September 2017*Canis familiaris*Duala, Monrovia North, LiberiaYesNoNegative9DBS/05221 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative10DBS/06727 September 2017*Canis familiaris*Duala (Monrovia North), LiberiaYesNoNegative11DBS/06929 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative12DBS/07029 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative13DBS/07129 September 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative14DBS/07229 September 2017*Canis familiaris*Paynesville, MonroviaYesNoNegative15DBS/07302 October 2017*Canis familiaris*Paynesville, MonroviaYesNoNegative16DBS/07402 October 2017*Canis familiaris*Red light, Paynesville, Monrovia, LiberiaYesNoNegative17DBT/07502 October 2017*Canis familiaris*Paynesville, MonroviaYesNoPositive; GenBank Accession No. MH50733618DBS/07602 October 2017*Canis familiaris*Paynesville, MonroviaYesNoPositive; GenBank Accession No. MH50733719DBS/07703 October 2017*Canis familiaris*Red light, Paynesville, LiberiaYesNoNegative20DBS/07803 October 2017*Canis familiaris*Paynesville, MonroviaYesNoNegative[^1]

Laboratory investigations {#sec2-5}
-------------------------

RNA extraction

One gram of brain tissue was homogenised and 9 ml of PBS was added and centrifuged in a refrigerated centrifuge at 10 000 rpm for 5 min to make 10% tissue suspension. Total RNA was extracted using QIAamp^®^ Viral RNA Mini Kit (QIAGEN, Hilden, Germany), according to the manufacturer\'s guidelines. The quality (260/280 nm) and concentration (ng/μl) of the extracted RNA was measured using the Eppendorf Biophotometer Plus^®^ UV-Visible Spectrophotometer (Eppendorf, Hamburg, Germany). The sample was immediately stored at −20 °C until further analysis. Detection of the nucleoprotein (N) gene of lyssaviruses by reverse transcription polymerase chain reaction (RT-PCR)

Detection of the N gene of lyssaviruses by RT-PCR was performed using the GeneAmp^®^ Gold RNA PCR Core Kit (Applied Biosystems, Foster City, CA, USA), according to the manufacturer\'s guidelines. Three oligonucleotide primers namely JW12 (+), Lys001 (+) and 550B (+) were selected for use in this study, based on their annealing positions on Pasteur Virus (GenBank Accession Number M13215) ([Table 2](#tab02){ref-type="table"}), as previously described \[[@ref12], [@ref13]\]. The primers were synthesised at Inqaba Biotechnical Industries (Pretoria, South Africa). The stages of the RT-PCR assay were as follows: Reverse transcription (RT) Table 2.Primers used for RT-PCR assay for amplification of the *N* gene of lyssavirusesPrimer (sense)DetectionPosition according to Pasteur virus nucleoprotein (N) gene[^a^](#tfn2_1){ref-type="table-fn"}Nucleotide sequence 5′--3′PurposeReferences001Lys (+)RABV1--15ACGCTTAACGAMAAAcDNA synthesis, PCR and sequencing\[[@ref12]\]JW12 (+)Pan-Lyssavirus55--73ATGTAACACCTCTACAATGcDNA synthesis\[[@ref13]\]550B (−)RABV, LBV647--666GTRCTCCARTTAGCRCACATPCR and sequencing\[[@ref12]\][^2]

Complementary DNA (cDNA) was produced by RT reaction using the following protocol: 1.0 µl of forward primer JW12 (20 µ[m]{.smallcaps}) was added to 1.0 µl of forward primer 001lys (20 µ[m]{.smallcaps}), 7.0 µl of nuclease-free water (NFW) and 2 µl of total RNA. The mixture was incubated at 65 °C for 2 min and cooled on ice for 5 min, to heat denature and anneal it with the primers. This was followed by RT at 37 °C for 60 min, 85 °C for 5 min, 37 °C for 10 min, 72 °C for 5 min and cooling at 4 °C, in a final volume of 20 µl containing 2 µl. A 1× reverse transcriptase buffer, 4.0 µl of deoxynucleoside triphosphate (dNTP) mixture (10 m[m]{.smallcaps}), 0.5 µl MultiScribe™ Reverse Transcriptase (15 U/μl) and 0.5 µl of Ribonuclease inhibitor (20 U/μl). PCR assay

Primary and secondary amplification of the cDNA (template) was performed using the primers 001lys and 550B, as previously described \[[@ref12]\]. Briefly, a lyophilised anti-rabies vaccine (low egg passage Flurry Strain) from NVRI served as the positive control in the PCR. A non-template blank served as the negative control. Primary amplification of 5.0 µl of the cDNA template was performed in a final volume of 50 µl containing 4.0 µl of 001lys (20 µ[m]{.smallcaps}), 4.0 µl of 550B (20 µ[m]{.smallcaps}), 24.75 µl of NFW, 5.0 µl of 10× buffer, 3.0 µl of MgCl~2~ (25 m[m]{.smallcaps}), 4.0 µl of dNTP mixture (10 m[m]{.smallcaps}) and 0.25 µl of AmpliTaq polymerase (5 U/μl).

For the secondary amplification reaction mixture (50.0 µl), 5.0 µl of primary PCR product (1:50 dilution) was used as a template and the conditions repeated as for the primary amplification. Both amplification reactions were performed on a GeneAmp^®^ PCR System 9700 (Applied Biosystems). After denaturation at 95 °C for 1 min, reactions were cycled 40 times at 94 °C for 30 s, 37 °C for 30 s and 72 °C for 90 s, with final extension at 72 °C for 10 min. False-positive results were avoided by following the standard precautionary measures for PCR \[[@ref14]\].

Electrophoresis and gel documentation

The final PCR products/genes were visualised on 1% agarose gel stained with ethidium bromide using ultraviolet light, following electrophoresis at 100 volts for 40 min. Sequence determination

The PCR product was purified using ExoSAP-IT™ (Affymetrix Inc., Santa Clara, California, USA), according to the manufacturer\'s guidelines. The purified product was sequenced in both forward and reverse direction using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems), according to the manufacturer\'s guidelines. The labelled product was then cleaned with the Zymo DNA Clean & Concentrator™−5 kit (Zymo Research Corporation, Irvine, California, USA), with subsequent analysis on an ABI3500XL genetic analyser with a 50 cm array (Applied Biosystems Inc.), using POP-7™. Phylogenetic analysis

The forward and reverse complement sequence reads (derived from the reverse sequence file using <http://www.bioinformatics.org/sms/rev_comp.html>) were combined into one contiguous sequence at the region of overlap of the two, using CAP3 sequence assembly program \[[@ref15]\]. The sequence was edited manually using BioEdit Sequence Alignment Editor Version 7.2.6.1 software \[[@ref16]\]. The edited sequence was used for a Megablast search (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>) for highly similar nucleotide sequences in GenBank^®^ database. The N genes of three vaccine strains SRV9 (AF499686), PV (GU992322) and SAD Vnukovo (GU992319) were also included in the list used for phylogenetic analysis of the Monrovia virus. Detailed information about all the sequences included in the phylogenetic analysis is provided in [Table 3](#tab03){ref-type="table"}. The sequences were aligned using the Multiple Sequence Comparison by Log- Expectation (MUSCLE) option provided in the Molecular Evolutionary Genetics Software Version 7 (MEGA7) \[[@ref17]\]. Pairwise genetic distances between sequences were estimated using the Kimura two-parameter substitution model \[[@ref18]\], ([Table 4](#tab04){ref-type="table"}). The results were used to construct a maximum likelihood tree using MEGA7. The phylogenetic tree was rooted to MOKV genotype 3 (EU293117) and other rabies-related lyssaviruses. Bootstrapping of 1000 replicates was used to statistically evaluate the branching order of the phylogenetic trees. The percentage of replicate trees in which the various strains clustered together is displayed next to the branches. A bootstrap support of 70% was considered significant and sufficient evidence for phylogenetic grouping \[[@ref19]\]. Table 3.Rabies lyssaviruses included in the phylogenetic analysis of the Monrovia rabies isolates MF765758, MH507336 and MH507337GenBank Accession No.Collection (year)CountryHost speciesLineageAB094438.12002Kyrgyzstan*Myotis blythi* (bat)Outgroup *Lyssavirus*KC169985.12012France*Myotis naterreri* (bat)OutgroupAY573943.12014Australia*Pteropus alecto* (bat)OutgroupEU293120.11981Republic of South Africa*Miniopterus* (bat)Outgroup *Lyssavirus*KF155004.12004UK*Myotis daubentonii* (bat)Outgroup *Lyssavirus*MF187859.11989France*Eptesicus serotinus*Outgroup *Lyssavirus*KX874609.12013Nigeria*Canis familiaris* (domestic dog)Africa 2KX874612.12010Nigeria*Canis familiaris* (domestic dog)Africa 2KX874613.12013Nigeria*Canis familiaris* (domestic dog)Africa 2MH507336 (this study)2017Liberia*Canis familiaris* (domestic dog)Africa 2MH507337 (this study)2017Liberia*Canis familiaris* (domestic dog)Africa 3JX193798.12009Tanzania*Civettictis civetta* (civet cat)Ikoma lyssavirus (outgroup)JX197457.12012China*Murina leucogaster* (bat)Irkut virus (outgroup)EF614261.1TajikistanBatKhujand lyssavirus (outgroup)EU293108.11985Senegal*Eidolon helvum* (bat)Lagos bat virus (outgroup)KY006983.12011Spain*Miniopterus schreibersii*Lleida bat lyssavirus (outgroup)GU170201.12009Kenya*Hipposideros commersoni*Shimoni bat virus (outgroup)EF614258.1RussiaBatWest Caucasian bat virus (outgroup)MH481711.12018LiberiaDogAfrica 2MH481712.12018LiberiaDogAfrica 2MH481713.12017LiberiaDogAfrica 2EU853577.11986TunisiaHumanAfrica 1aEU853580.11987EthiopiaBovineAfrica 1aU22643.11982AlgeriaDogAfrica 1bU22852.1MoroccoAfrica 1bKX148209.12004MadagascarDogAfrica 1cKX148210.11998MadagascarHumanAfrica 1cU22640.11990NigerDogAfrica 2U22639.11995Cote D' VoireAfrica 2EU718771.12006ChadDogAfrica 2KX148242.11994CameroonDogAfrica 2KF022180.12005NigeriaDogAfrica 2EU888728.12006NigeriaDogAfrica 2AF4679492002Republic of South AfricaMongooseAfrica 3DQ837431.11950IsraelDogAfrica 4DQ837461.11998EgyptDogAfrica 4KU963489.12005ChinaDogAsia (China 2)DQ6663222008ChinaDogAsia (China 2)MF765758 (this study)2006LiberiaDogAsiaU224821986IranDogAsiaU229181989NepalDogAsiaU224801990OmanRed foxAsiaU226541981GreenlandArctic foxOceaniaU224751991GermanyRed foxEurope/Mid. EastU427061986Bosnia-HerzegovinaRed foxEurope/Mid. EastEU2931171974 Cameroon*Crocidura sp*. (shrew)Mokola lyssavirus (outgroup)GU9923221993Morocco*Rabies virus* strain Pasteur (PV)GU9923191995Czech RepublicVaccine strain SAD Vnukovo Table 4.Estimates of evolutionary distances between N gene sequences of selected rabies lyssaviruses available in NCBI GenBank and Monrovia rabies lyssavirus isolate MF765758.![](S0950268818003333_inline1.jpg)

In view of limitations encountered in the use of MEGA for phylogenetic analysis of particularly short sequences, a complementary phylogram of the detected RABV N-sequences was generated using the Maximum Likelihood algorithm and subtree-pruning-regrafting branch-swapping option in PhyML version 3.0 (PhyML3) software \[[@ref20]\].

Results {#sec3}
=======

Gel documentation imagery {#sec3-1}
-------------------------

Three (15%) of 20 specimens (19 brain samples of suspected rabid dogs and one human saliva) tested were positive for RABV N gene by RT-PCR. The gel documentation of PCR products of the three positive genes are shown in [Figures 2](#fig02){ref-type="fig"} and [3](#fig03){ref-type="fig"}. Each gene was within 550--650 bp size range. The DBS 01, DBS 075 and DBS 076 sequences were 554, 171 and 126 bp ORF, respectively. Fig. 2.Partial amplification products of Lyssavirus N gene on 1% agarose gel, visualised with UV light; lane 1, marker (50 base pairs DNA ladder); lane 2, Monrovia dog brain sample (Lab Id. No: CCPZUI/DBS/01); lane 3, positive control; lane 4, negative control. Fig. 3.Partial amplification products of Lyssavirus N gene on 1% agarose gel, visualised with UV light; in lane 1 is the 100 bp DNA ladder while in lanes 2--5 are Monrovia samples nos. DBS/039, DBS/052, DBS/075 (GenBank Accession No. MH507336) and DBS/076 (GenBank Accession No. MH507337), respectively.

Partial N gene characteristics {#sec3-2}
------------------------------

These three sequences were deposited in GenBank, under accession numbers MF765758, MH507336 and MH507337, respectively. The Monrovia RABV sequence MH765758 had very close resemblance (99% homology) with China lineage 2 RABV strains KU963489 (or SN2-62-CanineCHINA2005) and DQ666322 (or Jiangsu_Yc63), previously isolated from dogs in China ([Table 4](#tab04){ref-type="table"}). The second RABV sequence obtained in Monrovia MH507336 clustered with Africa lineage 2 RABVs from Côte d\'Ivoire, Nigeria, Chad, Cameroon and Egypt, while the third RABV sequence MH507337 clustered with Africa lineage 3 RABVs AF467949 and JX088732 ([Fig. 4](#fig04){ref-type="fig"}). Africa lineage 3 RABVs were previously reported only in Southern Africa viverrids \[[@ref21]\]. Fig. 4.Maximum likelihood (ML) phylogenetic tree of the first Monrovia RABV N-gene isolate (GenBank Accession No. MF756758) generated using ML algorithm (1000 bootstrap replications). The analysis involved 50 nucleotide sequences. All positions with \<95% site coverage were eliminated. Evolutionary analyses were conducted in MEGA7 \[[@ref17]\]. The bootstrap values (%) are shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Kimura two-parameter method \[[@ref18]\] and are in the units of the number of base substitutions per site.

A complementary (second) phylogenetic tree generated using PhyML3 is shown in [Figure 5](#fig05){ref-type="fig"}. Again, the first Monrovia sequence MF765758 clustered with China strain, KU963489 (canine origin) and DQ666322 (canine origin). The MH507336 sequence segregated along with Africa lineage 2 RABVs strains, while MH507337 clustered with RABVs of Europe/Middle East lineage including U22480.1 (Oman), U22482.1 (Iran) U22475.1 (Germany) and U42706 (Bosnia-Herzegovina) ([Fig. 5](#fig05){ref-type="fig"}). Fig. 5.Maximum likelihood (ML) phylogenetic tree of the MH507336 and MH507337 generated using ML algorithm. The analysis involved 39 nucleotide sequences. Evolutionary analyses were conducted in PHYML3 \[[@ref20]\]. The bootstrap values (%) are shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Kimura two-parameter method \[[@ref18]\] and are in the units of the number of base substitutions per site.

Discussion {#sec4}
==========

This study was aimed at detecting and characterizing RABV strains circulating in Monrovia city and environs in Liberia, West Africa, 2016--2017, by RT-PCR testing of archived brain specimens of suspected rabid dogs using primers specific for the N gene of lyssaviruses, followed by sequencing analysis of the amplicons obtained. Three strains of RABV sequences were detected and accessioned in NCBI GenBank. All three isolates were from the Red Light area of Paynesville, a commercial district and notable slum located in the suburb of Monrovia, the capital city of Liberia. While the first report of DTHR in Liberia dates back to the 1950s \[[@ref2]\], there are no reports on molecular characteristics of RABVs from Liberia that predate our characterisation of the three Monrovia RABV strains that were identified in this study. The co-circulation of China lineage-2 with Africa lineage-2 and lineage-3 was probably due to inadvertent importation of rabies virus into Liberia from China or neighbouring countries, as a result of detection failure along import barriers. This allusion is plausible with recent findings that show the predominance of China sourced rabies vaccines in Nigeria \[[@ref22]\] and the all-time high Chinese presence in Liberia; while rabies vaccine quality compromise has been widely reported in China with resultant rabies outbreak following dog bite in humans \[[@ref23], [@ref24]\]. The direct importation of dogs considered vaccinated, yet incubating rabies is the most likely source of introduction of the China lineage 2 RABV into Liberia.

The phylogenetic results of this study revealed similarity of the Monrovia RABV MF765758 with DQ666322 or Jiangsu_Yc63 (China lineage 2) and other RABV lineages including Africa 1A-1C, Africa 4, Europe/Middle East and Asia, and vaccine strains PV (GU992322), SRV9 (AF499686) and SAD Vnukovo (GU992319) ([Figs 4](#fig04){ref-type="fig"} and [5](#fig05){ref-type="fig"}). The Chinese lineage C (especially C1) RABVs are closely related to rabies vaccine strains PV and SAD \[[@ref25]\]. Incidentally, antirabies vaccines that are used for dog immunisations in Monrovia and environs in Liberia are the inactivated Czech strains SAD Vnukovo-32 and PV Op VB. Clustering of the Liberian RABV strain MH507337 with RABV strain AF46794 regarded as a mongoose adapted strain previously isolated only in the southern African region \[[@ref21]\], constitutes another unique finding of this study, and warrants further detailed investigation to ascertain its host species and transmission mechanisms in Monrovia. It is also necessary to determine whether MF765758 the Chinese strain discovered in a Monrovia dog resulted in a self-terminating outbreak or perpetual propagation.

The short strands of MH507336 and MH507337 genes accounted for their sub-optimal positioning on the phylogram. This limitation was further resolved in PhyML3 which presents a robust platform and ML algorithm applicable to the phylogenetic analysis of RABVs \[[@ref26]\]. The recent discovery of three newly accessioned rabies N-genes from Liberia obtained from specimens collected through the CVLC in Monrovia, through an ongoing multi-national effort \[[@ref27]\], further clarified the phylogenetic relationship of these sequences. These latest RABV sequences segregated along with others that belong to Africa lineage 2 ([Figs 4](#fig04){ref-type="fig"} and [5](#fig05){ref-type="fig"}). This corroborates with predominance of Africa lineage 2 strains that are indigenous to West Africa being in circulation in Liberia.

Phylogenetic studies have shown that RABV isolates tend to form distinct groups and patterns of distribution that are each associated with specific geographical regions of the world \[[@ref28]\]. Africa lineage 1 RABVs closely resemble RABVs from Europe and Asia and are thought to be recently introduced into Africa from Europe \[[@ref29]\]. On the other hand, Africa lineage 2 RABVs comprise wild-type strains that originated from several central and eastern African countries, and are ancestral to Africa 1 and Eurasian RABVs \[[@ref30]\]. The phylogenetic evidence gathered in this study suggests that the Monrovia RABV isolate (MF765758) has its origin in Asia, rather than it being an autochthonous (Liberian) RABV or an extant strain from another African country. Till date, only Africa lineages 1 and 2 RABVs have been isolated from rabid dogs in West and Central Africa \[[@ref31]--[@ref33]\], and to the best of our knowledge, this is the first report from any African country of a RABV isolate of domestic dogs that is phylogenetically closely related to RABVs circulating in China.

It is plausible that other lyssaviruses apart from RABV are involved in recurrent outbreaks of rabies in Monrovia and other parts of Liberia because more than 56 different species of bats have been documented in different ecological zones of the country \[[@ref34]\], and all lyssaviruses with the exception of MOKV and IKOV are maintained in bats \[[@ref35]\]. In neighbouring West African countries such as Nigeria and Ghana, enzootic LBV exposures have been detected in *Megachiroptera* bats especially *Eidolon helvum* \[[@ref36], [@ref37]\]. Although there are no reported spill-overs of LBV into humans, LBV infections have been detected in dogs \[[@ref38]\] and wildlife such as mongoose \[[@ref12]\]. Such infections are of concern to public health authorities because of the likelihood that lyssavirus infections such as LBV may yet spill-over into the human population in future, and the available vaccines against RABV genotype 1 offer no protection against LBV.

While the goal of achieving a more effective and efficient detection, surveillance and stepwise elimination of animal and human rabies in West African cities and villages deserves stronger collaboration among African scientists, governments and beyond, current trends on epidemiological reports on one-health action against rabies presented at the 5th International Conference on Rabies in West Africa (RIWA), Bamako, Mali, 23--25 October 2018 show gradation in rabies one-health actions within the Economic Community of West African States (ECOWAS countries). Retrospective studies of DBVs presented for rabies exposure treatment in Buchanan, Suakoko and Voinjama, 2008--2013 showed that more than half of the DBVs were below 20 years of age, mostly male \[[@ref3]\]. They were comparable to what obtained in Bamako city, Mali. Finally, while it was shown that canine rabies transmission to humans can be interrupted in an African city with currently available dog rabies vaccines, provided that the vaccination area includes larger adjacent regions, and local communities are informed and engaged \[[@ref26]\], the higher education participation concept for developing more effective rabies surveillance and systematic elimination through mentorship programme in collaboration with one-health activities of ECOWAS governments and through Regional Rabies Control Strategies Elaboration and Validation Workshop is critically important to achieve the 2030 goal of elimination of rabies in Africa.

Conclusions {#sec5}
===========

This study is the first to confirm *RABV* infection by molecular diagnostic technique in Liberia. A canine rabies virus variant likely to have been imported from Asia was found co-circulating with Africa lineages 2 and 3 RABVs at the dog--human interface in Monrovia, Liberia, during outbreaks of DTHR that occurred between 2016 and 2017. While there is a need to investigate the yet unknown involvement of wildlife in the maintenance and spread of rabies in Liberia, efforts should be focused on improving rabies surveillance and reporting in Liberia. An in-country rabies diagnostic laboratory that complies with the World Organization for Animal Health procedures should be established in Liberia. The current findings should stimulate more efforts towards rabies active surveillance in one-health mode within the Economic Community of West African States, particularly within the Regional Rabies Control Strategies Elaboration and Validation Workshop.

The authors wish to thank the staff at the Central Veterinary Laboratory, Fendel, Monrovia and the Biotechnology Division of the National Veterinary Research Institute, Vom, Plateau State, Nigeria, for their technical contributions to the study. The authors also wish to specially thank Dr Abdurahman A. Niazy of King Saud University, Riyadh, Kingdom of Saudi Arabia for valuable discussions.

Conflict of interest {#nts3}
====================

None.

Ayodeji Olarinmoye, [0000-0001-8285-0858](0000-0001-8285-0858).

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

[^1]: Three serial samples collected from the patient over a period of 6 h.

[^2]: Pasteur virus (NCBI GenBank Accession Number M13215).
